The WinPro trial: window-of-opportunity study of endocrine therapy with micronised progesterone in ER-positive breast cancer.
- DOI
- 10.1038/s41523-026-01008-w
- Published
- 2026 Jul 21
- Container
- NPJ breast cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41523-026-01008-w,
title = {The WinPro trial: window-of-opportunity study of endocrine therapy with micronised progesterone in ER-positive breast cancer.},
author = {Haggstrom L and Middleton K and Parker A and Segara D and Ong A and Bingham J and Carson EK and Kiely BE and Sabanathan D and Spillane A and Saw K and Serrano A and Lindeman GJ and Swarbrick A and Coates A and Mann GB and Tilley W and Lim E},
year = {2026},
journal = {NPJ breast cancer},
doi = {10.1038/s41523-026-01008-w},
url = {https://doi.org/10.1038/s41523-026-01008-w}
}RIS
TY - JOUR TI - The WinPro trial: window-of-opportunity study of endocrine therapy with micronised progesterone in ER-positive breast cancer. AU - Haggstrom L AU - Middleton K AU - Parker A AU - Segara D AU - Ong A AU - Bingham J AU - Carson EK AU - Kiely BE AU - Sabanathan D AU - Spillane A AU - Saw K AU - Serrano A AU - Lindeman GJ AU - Swarbrick A AU - Coates A AU - Mann GB AU - Tilley W AU - Lim E PY - 2026 JO - NPJ breast cancer DO - 10.1038/s41523-026-01008-w UR - https://doi.org/10.1038/s41523-026-01008-w ER -
APA
L, H., K, M., A, P., D, S., A, O., J, B., EK, C., BE, K., D, S., A, S., K, S., A, S., GJ, L., A, S., A, C., GB, M., W, T., & E, L. (2026). The WinPro trial: window-of-opportunity study of endocrine therapy with micronised progesterone in ER-positive breast cancer.. NPJ breast cancer. https://doi.org/10.1038/s41523-026-01008-w
Source records
- pubmed · retrieved 2026-09-26T20:23:14.069Z